Accelerated cell therapy manufacturing with optimized microbial quality control

Tuesday 08:00 PDT / 11:00 EDT / 16:00 BST / 17:00 CEST

Sponsor

Accelerated cell therapy manufacturing with optimized microbial quality control

Live30 webinars pack the latest innovations and applications into a data-rich 30-minute session.

Discover how rapid microbiological methods can reduce your turnaround time in cell therapy manufacturing while remaining compliant with evolving regulatory expectations. This webinar will provide actionable insights on the importance of contamination control strategies and how to implement rapid QC methods that address the unique needs of cell therapy. It will further highlight the challenges that manufacturers face in microbial QC.

The speaker will discuss approaches for strengthening contamination control and tailoring QC approaches to improve product release timelines. Supporting data on rapid sterility testing will demonstrate how optimizing incubation conditions and supplementing culture media can significantly enhance detection timelines.

By the end of this session, attendees will be able to evaluate the potential of rapid methods for their own workflows, align their QC strategies with regulatory trends, and consider solutions that accelerate operational efficiency to contribute to better patient & market access.

Attend this webinar to:

Understand how rapid QC methods can significantly reduce time-to-detection and accelerate product release
Gain clarity on evolving regulatory expectations for microbial quality control in cell therapy
Learn how to benchmark your contamination control strategy against industry best practices

Juliana Gutierrez

Scientific Affairs Manager - Pharma Quality Control ASPAC at bioMérieux Japan Ltd

Dr. Juliana Gutierrez is Scientific Affairs Manager at bioMérieux, where she provides scientific and regulatory expertise to support the Pharma Quality Control segment across Asia. She holds a Ph.D. in Molecular Biology and has authored several peer-reviewed papers in the field. Juliana is an active member of the International Society for Cell & Gene Therapy (ISCT), serving on the ISCT Asia Pacific Industry Committee, and a member of the Parenteral Drug Association (PDA). She is also a frequent guest speaker at international conferences.

Roisin McGuigan

at BioInsights

You have registered for this webinar